LUXUS Aesthetics Colorado
- PRP Therapy
- Shockwave Therapy
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
Colorado Springs, CO
Colorado Springs's IV therapy market is shaped by altitude (roughly 6,000 feet), a massive military population (Fort Carson, Peterson and Schriever Space Force Bases, the Air Force Academy), and a tourism-heavy economy driven by Pikes Peak, Garden of the Gods, and the Olympic Training Center. Clinics cluster in Briargate, near Old Colorado City, and along Academy Boulevard, with overflow volume from Monument and Woodland Park. UCHealth Memorial Hospital, Penrose-St. Francis (Centura Health), and Children's Hospital Colorado at Memorial anchor the clinical ecosystem supplying medical directors. Colorado is a full-practice state for nurse practitioners, so NP-led IV clinics are common. Altitude-related hydration demand is real, especially for tourists. Military and spouse wellness drives steady B12 and vitamin C volume, Pikes Peak Ascent and Ironman-affiliated training support athletic recovery, and Olympic and Paralympic Training Center traffic adds a distinct athletic category.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Colorado medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.